Breaking News Instant updates and real-time market news.

SNY

Sanofi

$47.93

-0.0378 (-0.08%)

, MRK

Merck

$62.30

-0.54 (-0.86%)

15:33
08/08/17
08/08
15:33
08/08/17
15:33

Sanofi announces filing of patent infringement suit against Merck

Sanofi (SNY) announced that it filed a patent infringement suit against Merck (MRK) on August 8 in the United States District Court for the District of New Jersey. In its suit Sanofi alleges infringement of two patents. The suit was triggered by a notification received from Merck in late June, in which Merck stated that it had filed an NDA with FDA for an insulin glargine vial drug product. Merck also stated that its NDA included a paragraph IV certification challenging all of the Sanofi patents then listed in the FDA Orange Book for Sanofi's Lantus and Lantus SoloStar products.

SNY

Sanofi

$47.93

-0.0378 (-0.08%)

MRK

Merck

$62.30

-0.54 (-0.86%)

  • 28

    Aug

  • 22

    Sep

SNY Sanofi
$47.93

-0.0378 (-0.08%)

07/10/17
PIPR
07/10/17
NO CHANGE
Target $126
PIPR
Overweight
Alnylam shares overreacting to ALT elevations in OLE data, says Piper Jaffray
Alnylam (ALNY) and partner Sanofi (SNY) presented new Phase II open-label extension study data on 33 hemophilia patients being treated with fitusiran and reported that eleven patients reported asymptomatic ALT increases, up from three observed in its ASH meeting update, noted Piper Jaffray analyst Edward Tenthoff. However, he thinks the stock is overreacting, as the liver enzyme elevations were asymptomatic and largely reversed within one month, he tells investors. Tenthoff, who also sees the efficacy data as encouraging, reiterates his Overweight rating and $126 price target on Alnylam shares.
07/14/17
WELS
07/14/17
NO CHANGE
Target $41
WELS
Outperform
Wells says smallpox vaccine deal an 'excellent fit' for Emergent BioSolutions
Wells Fargo analyst David Maris said Emergent BioSolutions' (EBS) deal to acquire the ACAM2000 smallpox vaccine business of Sanofi (SNY) is "an excellent fit" and he is "encouraged" by its ability to identify and make a deal for such a "solid target." Maris keeps an Outperform rating and $41 price target on Emergent BioSolutions.
07/31/17
PIPR
07/31/17
NO CHANGE
Target $557
PIPR
Overweight
Regeneron indicated lower after Sanofi earnings report, says Piper Jaffray
Piper Jaffray analyst Edward Tenthoff says shares of Regeneron (REGN) are indicated lower after partner Sanofi (SNY) reported Q2 U.S. Dupixent sales of $30M in adults with atopic dermatitis. This was essentially in line with the consensus estimate of $33M, Tenthoff tells investors in a research note. He adds that over 5,100 physicians have prescribed and over 13,000 atopic dermatitis patients have been prescribed Dupixent as of July 26. The analyst views the launch stats as impressive and reiterates an Overweight rating on Regeneron with a $557 price target.
07/31/17
ADAM
07/31/17
NO CHANGE
Target $522
ADAM
Buy
Dupixent authorization approval rate outweighs Q2 miss, says Canaccord
Regeneron (REGN) partner Sanofi (SNY) reported a "very high" 73%-83% prior authorization approval rate for Dupixent in Q2, which Canaccord analyst John Newman said outweighs the fact that sales for the drug at $30.6M were slightly below the $33M consensus forecast. The analyst, who sees rapid payor acceptance of Dupixent as "much more crucial" than the initial quarterly revenue, keeps a Buy rating and $522 price target on Regeneron shares.
MRK Merck
$62.30

-0.54 (-0.86%)

07/27/17
GSCO
07/27/17
NO CHANGE
GSCO
Merck could trade up $5 following AstraZeneca MYSTIC failure, says Goldman Sachs
Goldman analyst Jami Rubin expects Merck (MRK) to trade up approximately $5 based on sentiment following AstraZeneca's MYSTIC failure as it partially de-risks longer-term estimates for Keytruda. As a result, the analyst raised Merck's Keytruda sales estimates by $600M in 2018 and $1B in 2019 and beyond, increasing earnings estimates by 14c-20c, and raising his price target on shares to $74 from $70. Rubin cautions that long-term estimates could be at risk if other competitor trials are successful. The analyst rates Merck a Neutral.
07/27/17
FBCO
07/27/17
NO CHANGE
FBCO
Merck unlikely to buy PARP company after Astra deal, says Credit Suisse
Credit Suisse analyst Alethia Young believes Merck (MRK) is unlikely to acquire a PARP inhibitor company like Tesaro (TSRO) or Clovis (CLVS) after inking an immuno-oncology deal with AstraZeneca (AZN).
07/27/17
JANY
07/27/17
NO CHANGE
Target $107
JANY
Buy
PARP deals may make Clovis more attractive buyout candidate, says Janney
The partnerships announced today between AstraZeneca (AZN) and Merck (MRK) as well as Tesaro (TSRO) and Takeda highlight pharma's willingness to expand on PARP's, Janney analyst Debjit Chattopadhyay tells investors in a research note. Clovis' (CLVS) Rubraca is now the only unencumbered PARP and is "far cheaper" on a relative valuation basis than peer Tesaro, the analyst adds. He believes Clovis could now become a more compelling takeover candidate. Chattopadhyay has a Buy rating on the shares with a $107 price target. The stock in midday trading is up 7%, or $5.90, to $93.33.
07/28/17
RHCO
07/28/17
NO CHANGE
RHCO
Merck, AstraZeneca deal positive, says SunTrust
After Merck (MRK) paid $1.6B upfront for access to Astrazeneca's (AZN) PARP inhibitor, Lynparza and another drug, SunTrust analyst John Boris says that the deal "makes strategic/financial sense and validates the PARP inhibitor class." He adds that the companies are "ideally positioned" to leverage a combination of IO and PARP therapies. The analyst reiterates a $73 price target and a Buy rating on Merck.

TODAY'S FREE FLY STORIES

UBX

Unity Biotechnology

$14.27

0.27 (1.93%)

08:26
12/11/18
12/11
08:26
12/11/18
08:26
Conference/Events
Unity Biotechnology to hold an event on cellular senescence »

Experts discuss the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

BCO

Brink's

$61.97

-0.13 (-0.21%)

08:26
12/11/18
12/11
08:26
12/11/18
08:26
Hot Stocks
Brink's enters $50M accelerates share repurchase »

Brink's announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 11

    Dec

  • 12

    Dec

CAMP

CalAmp

$17.02

-0.23 (-1.33%)

08:25
12/11/18
12/11
08:25
12/11/18
08:25
Downgrade
CalAmp rating change  »

CalAmp downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Dec

DVMT

Dell Technologies

$104.13

0.12 (0.12%)

08:25
12/11/18
12/11
08:25
12/11/18
08:25
Conference/Events
Dell Technologies to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 07

    Mar

AWK

American Water

$97.50

-0.22 (-0.23%)

08:25
12/11/18
12/11
08:25
12/11/18
08:25
Conference/Events
American Water to host investor day »

Investor Day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

ENB

Enbridge

$31.40

-0.54 (-1.69%)

08:25
12/11/18
12/11
08:25
12/11/18
08:25
Conference/Events
Enbridge to hold investor conference »

2018 Enbridge Day--Annual…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

CNNE

Cannae Holdings

$17.00

0.26 (1.55%)

08:25
12/11/18
12/11
08:25
12/11/18
08:25
Conference/Events
Cannae Holdings participates in a conference call with Stephens »

President Bickett and EVP…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 11

    Dec

ACRX

AcelRx

$3.34

-0.03 (-0.89%)

08:25
12/11/18
12/11
08:25
12/11/18
08:25
Conference/Events
AcelRx to hold an analyst and investor day »

Analyst and Investor Day…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

ARMK

Aramark

$35.48

-1 (-2.74%)

08:25
12/11/18
12/11
08:25
12/11/18
08:25
Conference/Events
Aramark to host investor day »

Investor Day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

HA

Hawaiian Holdings

$30.62

0.02 (0.07%)

08:25
12/11/18
12/11
08:25
12/11/18
08:25
Conference/Events
Hawaiian Holdings to host investor day »

Investor Day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

08:24
12/11/18
12/11
08:24
12/11/18
08:24
Conference/Events
DA Davidson to hold a bus tour »

Holiday Beauty Bus Tour…

PDRDY

Pernod Ricard

$0.00

(0.00%)

08:24
12/11/18
12/11
08:24
12/11/18
08:24
Conference/Events
Pernod Ricard management to meet with UBS »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

  • 13

    Dec

  • 13

    Dec

CBS

CBS

$49.78

-1.14 (-2.24%)

, CBS.A

$50.79

-0.43 (-0.84%)

08:24
12/11/18
12/11
08:24
12/11/18
08:24
Periodicals
CBS making little headway on finding permanent CEO, WSJ reports »

CBS has made little…

CBS

CBS

$49.78

-1.14 (-2.24%)

CBS.A

$50.79

-0.43 (-0.84%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 19

    Dec

  • 20

    Dec

DRH

DiamondRock

$9.88

-0.165 (-1.64%)

08:24
12/11/18
12/11
08:24
12/11/18
08:24
Downgrade
DiamondRock rating change  »

DiamondRock downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADUS

Addus HomeCare

$74.42

-0.02 (-0.03%)

, AMED

Amedisys

$129.11

-1.15 (-0.88%)

08:24
12/11/18
12/11
08:24
12/11/18
08:24
Conference/Events
Stephens to hold a plane trip »

Healthcare Services…

ADUS

Addus HomeCare

$74.42

-0.02 (-0.03%)

AMED

Amedisys

$129.11

-1.15 (-0.88%)

BKD

Brookdale Senior Living

$8.45

0.21 (2.55%)

EHC

Encompass Health

$71.41

0.26 (0.37%)

LHCG

LHC Group

$101.68

-0.42 (-0.41%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

BCO

Brink's

$61.97

-0.13 (-0.21%)

08:23
12/11/18
12/11
08:23
12/11/18
08:23
Hot Stocks
Brink's receives antitrust approval for $130M Rodoban acquisition »

Brink's announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 11

    Dec

  • 12

    Dec

NTNX

Nutanix

$43.17

1 (2.37%)

08:23
12/11/18
12/11
08:23
12/11/18
08:23
Conference/Events
Nutanix management to meet with KeyBanc »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 12

    Dec

  • 17

    Dec

  • 15

    Jan

08:23
12/11/18
12/11
08:23
12/11/18
08:23
Conference/Events
Morgan Stanley to hold a conference »

Travel & Leisure…

ACMR

ACM Research

$10.19

(0.00%)

, AEIS

Advanced Energy

$41.71

0.03 (0.07%)

08:22
12/11/18
12/11
08:22
12/11/18
08:22
Conference/Events
Companies to hold a summit »

The 7th Annual NYC Summit…

ACMR

ACM Research

$10.19

(0.00%)

AEIS

Advanced Energy

$41.71

0.03 (0.07%)

AEHR

Aehr Test Systems

$1.80

(0.00%)

AOSL

Alpha & Omega

$9.80

-0.14 (-1.41%)

ACLS

Axcelis

$18.22

-0.31 (-1.67%)

BRKS

Brooks Automation

$26.76

0.35 (1.33%)

COHU

Cohu

$17.40

0.62 (3.69%)

FORM

FormFactor

$15.30

0.34 (2.27%)

ICHR

Ichor Holdings

$16.43

-0.37 (-2.20%)

IMI

Intermolecular

$0.95

0.0133 (1.41%)

INTT

inTEST

$6.81

0.07 (1.04%)

IVAC

Intevac

$4.52

-0.115 (-2.48%)

KLIC

Kulicke & Soffa

$19.42

-0.13 (-0.66%)

NANO

Nanometrics

$28.78

0.31 (1.09%)

RTEC

Rudolph Technologies

$19.56

-0.095 (-0.48%)

VECO

Veeco

$7.42

-0.38 (-4.87%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 12

    Dec

  • 18

    Dec

  • 19

    Dec

SPY

SPDR S&P 500 ETF Trust

$264.09

0.41 (0.16%)

, SPX

S&P 500

$0.00

(0.00%)

08:21
12/11/18
12/11
08:21
12/11/18
08:21
General news
President Trump says 'very productive' talks going on with China »

President Donald Trump…

SPY

SPDR S&P 500 ETF Trust

$264.09

0.41 (0.16%)

SPX

S&P 500

$0.00

(0.00%)

DJX

Dow Jones Industrial Average

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$DJT

DJ Transportation Average

$0.00

(0.00%)

08:20
12/11/18
12/11
08:20
12/11/18
08:20
Technical Analysis
DJ Transportation Average: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$DJU

DJ Utility Average

$0.00

(0.00%)

08:20
12/11/18
12/11
08:20
12/11/18
08:20
Technical Analysis
DJ Utility Average: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RFL

Rafael Holdings

$8.60

0.11 (1.30%)

08:20
12/11/18
12/11
08:20
12/11/18
08:20
Hot Stocks
Rafael Pharmaceuticals initiates Phase 3 AVENGER 500 trial »

Rafael Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADOM

Adomani

$0.39

-0.0025 (-0.64%)

, AVD

American Vanguard

$15.14

0.06 (0.40%)

08:20
12/11/18
12/11
08:20
12/11/18
08:20
Conference/Events
Roth Capital to hold a conference »

6th Annual ROTH…

ADOM

Adomani

$0.39

-0.0025 (-0.64%)

AVD

American Vanguard

$15.14

0.06 (0.40%)

BWEN

Broadwind Energy

$1.55

-0.07 (-4.32%)

CECE

CECO Environmental

$7.80

-0.22 (-2.74%)

CWCO

Consolidated Water

$12.35

-0.51 (-3.97%)

HCHC

HC2 Holdings

$2.99

-0.04 (-1.32%)

JASN

Jason Industries

$1.69

-0.01 (-0.59%)

JE

Just Energy

$4.04

-0.165 (-3.93%)

LAKE

Lakeland Industries

$11.71

-0.4 (-3.30%)

LDL

Lydall

$20.05

-0.14 (-0.69%)

ORA

Ormat Technologies

$54.35

0.59 (1.10%)

WAAS

AquaVenture

$18.80

0.71 (3.92%)

UQM

UQM Technologies

$0.97

(0.00%)

TREC

Trecora Resources

$8.35

-0.03 (-0.36%)

SPKE

Spark Energy

$8.52

-0.18 (-2.07%)

REGI

Renewable Energy

$25.86

-0.36 (-1.37%)

WLDN

Willdan Group

$36.38

-1.07 (-2.86%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 12

    Dec

  • 12

    Dec

  • 13

    Dec

  • 14

    Dec

  • 18

    Dec

DJX

Dow Jones Industrial Average

$0.00

(0.00%)

08:20
12/11/18
12/11
08:20
12/11/18
08:20
Technical Analysis
Dow Jones Industrial Average: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.